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The effect of low intensity shockwave
treatment (Li-SWT) on human myoblasts
and mouse skeletal muscle
Lise K. Hansen1, Henrik D. Schrøder1,2, Lars Lund2,3, Karthikeyan Rajagopal4, Vrisha Maduri4 and Jeeva Sellathurai1,2*
Abstract
Background: Transplanting myogenic cells and scaffolds for tissue engineering in skeletal muscle have shown
inconsistent results. One of the limiting factors is neovascularization at the recipient site. Low intensity shockwave
therapy (Li-SWT) has been linked to increased tissue regeneration and vascularization, both integral to survival and
integration of transplanted cells. This study was conducted to demonstrate the response of myoblasts and skeletal
muscle to Li-SWT.
Method: Primary isolated human myoblasts and explants were treated with low intensity shockwaves and
subsequently cell viability, proliferation and differentiation were tested. Cardiotoxin induced injury was created in
tibialis anterior muscles of 28 mice, and two days later, the lesions were treated with 500 impulses of Li-SWT on one
of the legs. The treatment was repeated every third day of the period and ended on day 14 after cardiotoxin
injection.. The animals were followed up and documented up to 21 days after cardiotoxin injury.
Results: Li-SWT had no significant effect on cell death, proliferation, differentiation and migration, the explants
however showed decreased adhesion. In the animal experiments, qPCR studies revealed a significantly increased
expression of apoptotic, angiogenic and myogenic genes; expression of Bax, Bcl2, Casp3, eNOS, Pax7, Myf5 and Met
was increased in the early phase of regeneration in the Li-SWT treated hind limbs. Furthermore, a late accumulative
angiogenic effect was demonstrated in the Li-SWT treated limbs by a significantly increased expression of Angpt1,
eNOS, iNOS, Vegfa, and Pecam1.
Conclusion: Treatment was associated with an early upregulation in expression of selected apoptotic, pro-
inflammatory, angiogenic and satellite cell activating genes after muscle injury. It also showed a late incremental
effect on expression of pro-angiogenic genes. However, we found no changes in the number of PAX7 positive cells
or blood vessel density in Li-SWT treated and control muscle. Furthermore, Li-SWT in the selected doses did not
decrease survival, proliferation or differentiation of myoblasts in vitro.
Keywords: Li-SWT, Skeletal muscle regeneration, Vascularization, Angiogenesis, Myoblasts
Background
Satellite cell (Sc) derived myoblasts are widely used in
regenerative medicine for engineering skeletal muscle
tissue. Their successful transplantation, however, has
been hampered by poor survival and poor engraftment
in transplanted tissue [1–3]. Newer scaffolds have
improved the success rates of myoblast transplantation
[4, 5], but insufficient vascularization is still a limiting
factor [6]. Common methods for improving
vascularization include employment of gene-modified
cells expressing angiogenic factors and scaffolds releas-
ing angiogenic factors like VEGF and IGF1 [7, 8].
A promising, non-invasive, indirect technique to im-
prove vascularisation is a low intensity shockwave treat-
ment (Li-SWT). This is increasingly employed in
regenerative medicine and wound healing [9–11] al-
though clinical studies conducted so far have not
* Correspondence: jsellathurai@health.sdu.dk; jeeva.sel@gmail.com
1Department of Clinical Pathology, SDU Muscle Research Cluster (SMRC),
Odense University Hospital, Odense, Denmark
2Institute of Clinical Research, Faculty of Health Science, University of
Southern Denmark, Odense, Denmark
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Hansen et al. BMC Musculoskeletal Disorders  (2017) 18:557 
DOI 10.1186/s12891-017-1879-4
advocated the use of SWT in the clinic. More research is
needed to establish the clinical effect of SWT from a
clinical perspective. Shockwaves are transient high-
pressure acoustic pulses that can be generated by differ-
ent mechanical principles [12]. Shockwaves affect tissue
by a direct mechanical force and by creating bubble cav-
itations that burst, generating a jet flow affecting nearby
cells [12–14]. This results in minor intra- and extracellu-
lar damages, shear stress and conversion of mechanical
force into chemical activity (known as mechanotrans-
duction) [14, 15] inducing a regenerative response in the
involved tissue.
In vitro studies with Li-SWT have shown to en-
hance certain functions involved in the behavior of
specific cell types. Li-SWT increases proliferation, mi-
gration and secretion of collagenase in tenocytes
treated with 1000 impulses of 0.14 mJ/mm2 [16, 17].
Human osteoblasts treated with Li-SWT (500 im-
pulses, 0.06 and 0.5 mJ/mm2) show a dose-dependent
increase in proliferation and increased expression of
the genes PTHLP and PTGER3 which are involved in
bone development and osteoblast differentiation [18].
Li-SWT (300 impulses, 0.1 mJ/mm2) treated mouse
endothelial progenitor cells showed increased expres-
sion of angiogenic cytokines (specifically Vegf, Nos3,
Angpt1, Angpt2) and Kdr (a gene that codes for the
protein vascular endothelial growth factor receptor 2)
[19]. Primitive human cardiac cells showed increased
KDR protein levels when treated with Li-SWT (800
impulses, 0.1 mJ/mm2) [20].
In vivo studies with Li-SWT have shown improved
tissue regeneration, greater vascularization and al-
tered immune responses. Studies in rodents have
shown increased perfusion, survival, and vessel dens-
ity in skin flaps in addition to increased gene expression
of eNOS and Vegfa [21–23], and increased perfusion of is-
chaemic adductor muscle [24] after Li-SWT ranging from
200 to 750 impulses, (0.1 mJ/mm2). Altered immune re-
sponse was seen in cremaster muscle tissue as decreased
rolling and transmigration of leukocytes through the
endothelium as well as down regulation of iNOS gene
after Li-SWT (500 impulses 0.1 mJ/mm2) [25, 26].
Li-SWT is a widely used treatment of tendon and
bone-related conditions such as tendinopathy, plantar
fasciitis and non-union of bone [27]. In addition,
much ongoing research is focused on the ability of
Li-SWT to ameliorate muscle pain, spasticity and per-
ipheral arterial disease [28–30]. However, there are no
published results in the indexed literature on the ef-
fect of Li-SWT on myoblast and skeletal muscle re-
generation after acute injury. Thus, the question
whether Li-SWT can boost regeneration and improve
vascularisation of the muscle has not yet been
addressed.
Study objective
The objective of this study is to address the effects of Li-
SWT on regenerating skeletal muscle. For this purpose
we have conducted following studies:
1. An in vitro study on human myoblasts was
conducted to look selectively at the effects of Li-
SWT on myogenic stem cells.
2. An in vivo study was conducted in mice. The
animals received an acute myotoxic injury on tibialis
anterior muscle, followed by treatment with Li-SWT
to study the effect of Li-SWT on muscle
regeneration.
Methods
Shockwave application
A handheld Duolith SD1 equipment (Storz, Tägerwilen,
Switzerland) was set at the intensity 0.10 mJ/mm2, 5 Hz
(5 impulses pr. second), with 300, 500, 1000, or 1500 im-
pulses given continuously in one treatment lasting 60s,
100 s, 200 s, or 300 s respectively. The treated area was
covered with EKO GEL (ultrasound transmission gel,
Ekkomarine Medico A/S, Denmark) and the focused
shockwaves were delivered with a focal area (penetration
depth) at 0-30 mm.
For the in-vitro experiments, a cryotube (1.8 ml) filled
with Ultroser G (UG) medium containing 2.5 × 105 cells
and a cryotube filled with growth medium (GM which
consisted of DMEM with 10% FBS and 1% PSA (Penicil-
lin-Streptomycin-amphotericin B, Life Technologies))
containing pieces of muscle explants of approx. 0.5 cm3.
These were covered with EKO GEL and treated once
with 300, 500, 1000 or 1500 impulses of Li-SWT imme-
diately before culturing.
The control cells were transferred to cryotubes at the
same time as the samples treated with Li-SWT before
culturing, but did not receive shockwave treatment.
Myoblast isolation and culturing
Human myoblasts were isolated from biopsies taken
from the vastus lateralis muscle of young men (18–
20 years). These samples were obtained from a previous
study [31]. Biopsies free of connective tissue were
minced and digested with 0.3% collagenase type II (Med-
inova Scientific) for 40 min. in 37 °C water bath. The
suspension was titrated with a 1 ml pipette, cold HBSS
(Hanks Balanced Salt Solution) with 10% FBS was added
and the suspension was pelleted and re-suspended in
37 °C HBSS with 10% fetal bovine serum (FBS) and fil-
trated first through a 100 μm then through a 40 μm Fal-
con Cell Strainer. The isolated satellite cells were
cultured in GM and plated on extracellular matrix
(ECM, Sigma-Aldrich, MO, USA) coated dishes (Nun-
clon, Nunc). During every passage, the number of
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fibroblasts was reduced by pre-plating the cells for
20 min. at 37 °C on untreated NUNC dishes. The non-
adherent cells were harvested, expanded and aliquots
were frozen and kept in liquid nitrogen.
For the in vitro experiments the cells were thawed and
seeded on ECM (Extracellular Matrix, Sigma-Aldrich,
MO, USA) coated flasks and coverslips (Fischer
Scientific, MA, USA) and cultured in growth medium
(DMEM w. hepes and DMEM w. glutamat (Life
Technologies, CA, USA)) with 2% Ultroser G (Pall), 2%
FBS (Fetal bovine serum, Life Technologies) and 1% PSA
(Penicillin-Streptomycin-amphotericin B, Life Technologies).
Explant culture conditions
Human explants were obtained from the m.quardriceps
femoris and m. soleus (females aged 78 and 31), and cul-
tured in a growth medium with 10% FBS and 1% PSA.
The media was changed 9 days after Li-SWT and after-
wards twice a week and the explants were harvested
after 17 days.
Myoblast viability, proliferation and differentiation after
Li-SWT
Myoblast survival was measured by tryphan blue stain-
ing (Sigma-Aldrich) immediately after shockwave treat-
ment. In order to examine the proliferation rate after Li-
SWT, myoblasts were cultured in 10 mM BrdU in UG
media (cumulative BrdU incorporation), and coverslips
were harvested at days 1, 2, 3 and 4 after treatment. The
differentiation ability of myoblasts after Li-SWT was
tested by culturing them in a differentiation medium
(DMEM with 2% FBS, 1% PSA and 25 pM insulin
(Actrapid from Novo Nordisk, DK)) and cells were har-
vested on days 2, 4, and 6 after Li-SWT.
Animal experiment
Twenty-eight female mice aged 10 weeks (C57BL/
6NTac) received a single lesion in both of their tibialis
anterior muscle (TA) through an injection of 50 μl cardi-
otoxin, CTX (10 μM). Two days later the mice were
treated with Li-SWT for 100 s (500 impulses of 0.1 mJ/
mm2 (5 Hz), 1.635 joule) on the left leg, while the right
leg functioned as control. Prior to the shockwave appli-
cation, the skin of the leg was depilated to eliminate
shockwave interferences. The treatment was repeated
every third day of the period, ending on day 14 after
CTX injection. Four mice were euthanized at each time
point on days 2 (5 h after first Li-SWT treatment), 3, 5,
7, 10, 14 and 21 after cardiotoxin injection.
The TA muscles were removed from both legs and cut
into halves. One half was stored in RNAlater (Ambion,
Life technologies) in −20 C° for qPCR analysis. The
other half was fixed in formalin for 24 h and embedded
in paraffin for histological studies.
RT-qPCR
Cell cultures
Gene expression studies were performed with 3 bio-
logical replicates.
In order to examine gene expression under prolifera-
tion, cell cultures were harvested 5 h, 12 h, 24 h, 48 h,
72 h and 96 h after Li-SWT and lysed with 0.5–1 ml tri-
zol (Life Technologies, CA, USA).
Animal experiments
Of the four mice euthanized, three were used for RT-
qPCR. The muscles were lysed in 1 ml trizol using
MagNA lyser beads and processed on Magna Lyser In-
strument (Roche Applied science, DK) for 2 × 20 s at
6500 rpm, following this RNA was extracted.
cDNA was synthesized from 500 ng RNA using High
Capacity cDNA Reverse Transcription kit (Life Tech-
nologies) and qPCR performed on Quantstudie 12 K flex
(Life Technologies) using custom designed 384 well Taq-
Man Array Micro Fluidic Cards. The data were analysed
in qBasePlus (Biogazelle), and quality control was set by
excluding replicates with >0.5 deviation from quantifica-
tion cycle (Cq). Reference genes were selected using
Genorm (M–value <1.5). The results for the individual
genes are shown as mean fold change to the lowest nor-
malised Cq value, which was set to 1. The following
genes were examined in myoblast cultures: TGFb1,
SMAD3, SMAD7, MKI67, CYCLIND1, P21, TP53,
CASP3, PAX3, PAX7, MYF5, MYOD1, MYOG, MEF2A,
MET, HGF and KDR. GAPDH and TBP were used as ref-
erence genes.
In the animal experiment the genes examined were:
Bax, Bcl2, Casp3, Il1a, Il1b, Il6, Ccl2, Ccr2, Tnf, Pax7,
Myf5, Myod1, Myog, Myf6, Mstn, Met, Hgf, Mef2c, Tgfb1,
Angpt1, Angpt2, iNOS, eNOS, Vegfa, Kdr, Pecam1, Cd34,
Fgf2 and Fgfr1. Rn18s, Tbp and Tfrc were used as refer-
ence genes. All qPCR data (fold changes) for the in vitro
and in vivo experiments can be seen in Additional file 1.
Immunohistochemistry
Cell cultures
For detection of BrdU, samples were fixed in 96% alco-
hol for 30 min before incubation in 2 N HCL with 0.5%
Triton X-100 for 30 min. Afterwards samples were neu-
tralised for 3 × 5 min in NaBH4 solution (1 mg/ml),
followed by incubation of mouse-anti-BrdU (1:20, Bu20a
clone, Dako, DK).
For detection of NCAM, explant samples were fixed in
4% formalin for 5 min followed by incubation in Triton
X-100 for 5 min, prior to incubation with mouse-anti-
NCAM (1:100 CD56 Leu-19), Becton Dickinson, DK).
For detection of myogenin, samples were fixed 15 min
in 4% formalin followed by incubation in 96% ethanol
for 10 min. After rinsing in water the samples were
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incubated in Tris-EGTA buffer at 95 °C for 15 min,
followed by incubation with mouse-anti-myogenin
(1:800, F5D, Dako). Powervision (Leica Biosystems) was
used for detecting BrdU, NCAM and myogenin.
For detection of F-actin, samples were washed twice in
preheated (37°) TBS (Tris-buffered saline) and fixed in
4% formalin for 10 min and incubated in 0.1% Triton-
X100 for 5 min, before incubation in phalloidin (1:40,
Alexa Flour 546 Phalloidin, Lifetechnologies). After
washing with PBS, samples were mounted with
Vectashield (Vector Lab, UK).
In vivo experiment
Staining of muscle paraffin sections was carried out on
Dako Autostainer Plus (Dako) using Dako EnVision + kit
and the following antibodies: rabbit anti-rat IgG (Dako)
followed by rat-anti-Cd45 (1:100, 30-F11, Pharmingen,
BD, DK), rabbit-anti-vWF (1:2000, Dakopatts A/S, DK),
mouse-anti-myogenin (1:200, clone F5D, Dako) and
mouse-anti-Pax7 (1:20, Hybridoma Bank, IA, USA). The
sections were blocked for endogen biotin by Avidin/Bio-
tin Blocking kit (Vector Lab, UK) prior to incubation
with myogenin and pax7.
Morphometrics and statistical analyses
CAST software (Visiopharm A/S, Hørsholm, DK) was
used for all morphometric analysis. Systematic, random
counts were performed on blinded samples including
the entire cell containing area. In assessment of BrdU in-
corporation and cell adhesion 10% of the coverslip area
was counted, while 25% was counted when quantifying
myofibers (≥ 3 myogenin + nuclei) and 2% when deter-
mining the myogenin fraction in cell cultures.
Quantification of the immunostained paraffin sections
from the animal experiment was performed by counting
MYOG+, PAX7+ and CD45+ cells and vWF+ vessels in
100% of the selected areas (regenerating and non-
regenerating part of the TA muscle). As the size of the
muscle injury induced by cardiotoxin varied between an-
imals, the selected regenerating area varied, too, why the
data is presented as positive events per cm2.
Statistics were performed in Graphpad Prism, version
5.0 (Graph Pad Software Inc., LA, USA). All data are
shown in mean + SD (standard deviation) and results are
tested by paired t-test in order to detect difference be-
tween Li-SWT treatment and control. P-values below
0.05 were considered significant.
Results
In vitro cell survival, proliferation and apoptosis of
myoblasts were not affected by Li-SWT
Cells were treated with 300, 500, 1000 and 1500 im-
pulses of Li-SWT and cell death subsequently quantified
by tryphan blue uptake. Cell death was between 2.8–
5.6% in the Li-SWT treated compared to 1.7–3.0% in
controls, and thus we found no significant difference in
cell death (Fig. 1a).
The effect of Li-SWT on myoblast proliferation
was assessed by counting the number of cells on day
1, 2, 3 and 4 after treatment. The results showed
some variation between the three cell cultures, but
overall no significant difference between shockwave
treated and controls was observed (Fig. 1b), nor did
the BrdU incorporation studies demonstrate in-
creased proliferation in treated cells compared to
controls (Fig. 1c).
The expression of TGFB1 during proliferation was sig-
nificantly decreased at 12 h in the Li-SWT group, while
SMAD7 in this group at 12 h was significantly increased,
yet there was no difference between the groups in
SMAD3 and CASP3 expression (Fig. 1d). The cell cycle
related genes KI67, CYCLIND1 and P53 showed no dif-
ference in expression (Fig. 1d), except P21 was signifi-
cantly different at 12 h, 24 h and 72 h. Thus, the data
supports that Li-SWT exerted neither negative nor posi-
tive effects on cell survival and proliferation of
myoblasts.
No difference was observed in the expression of the
myogenic factors PAX3, PAX7, MYF5, MYOD1, MYOG,
MET, and HGF genes during proliferation. However,
MEF2A, a co-actor in myoblast differentiation [32], was
significantly increased at 12 h in the Li-SWT group com-
pared to control (Fig. 2).
Li-SWT did not influence the migration ability in vitro
A scratch test performed 48 h after Li-SWT treatment
with a duration of 18 h revealed no change in the ability
of human Li-SWT myoblasts to migrate compared to
controls. (See Additional file 2 for images and detailed
method).
Li-SWT did not alter myogenesis in vitro
In order to determine if shockwaves affect the differenti-
ation, myofiber (>2 nuclei) formation was quantified
after culturing in differentiation medium for 2, 4 and
6 days. As an additional parameter the fraction of
MYOG positive nuclei was estimated. Though no differ-
ence was seen in presence of myofibers (Fig. 3a), the
fraction of MYOG+ cells was significantly lower on day
2 in the Li-SWT group (Fig. 3b). Although the number
of MYOG+ cell thus seemed lower during induction of
differentiation, the capacity for myofiber formation and
the overall ability to differentiate was not impaired by
Li-SWT.
Decreased adhesion of explants after Li-SWT
We found that 46% of the Li-SWT treated explants com-
pared to 92% in controls (n = 48) adhered to the
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coverslips after 7 days (Fig. 4a). However, no difference
was seen in the extent of outgrown cells or NCAM pro-
tein expression in the Li-SWT group compared to con-
trols (Fig. 4b).
The adhesion kinetics of primary isolated myoblasts
(isolated by enzyme dissociation) were then tested by
treating the cells with Li-SWT followed by cell harvest
every 30 min for the first 2 h after seeding. No reduced
adherence following Li-SWT was seen in treated cells
compared to controls (Fig. 4c.). However, the expression
of F-actin, visualized by phalloidin staining, was reduced
in Li-SWT treated cells, indicating a delayed formation
of F-actin (Fig. 4d).
In vivo
The effects of Li-SWT on skeletal muscle regeneration
were studied in mouse muscle using a cardiotoxin-
induced lesion that provides a complete regenerating
microenvironment. The cardiotoxin lesion did not cover
the entire TA muscle, hence the histological sections
contained partly normal and partly regenerating area
(Additional file 3).
Fig. 1 Quantifications of cell death, total cell counts, BrdU incorporation in cell cultures and gene expressions of TGFB1, SMAD3, SMAD7, KI67,
CYCLIN D1, P21, P53 and CASP3 during myoblast proliferation. a Viability testing by tryphan blue at 300500, 1000 and 1500 impulses (0.1 mJ/mm2,
5hz) with 3 human cell cultures showed a small, but insignificant, increase in cell death after Li-SWT. b The myoblast proliferation was assessed in
controls and after Li-SWT by detaching and counting the cells every day for 4 days. Variation between cell cultures was found, but no effect of
Li-SWT was observed. c Proliferation was further investigated by BrdU incorporation followed by immunostainings, which revealed a 2% increase
in proliferation on day 1 after Li-SWT. d Gene expression study during proliferation revealed that TGFB1 expression was significant lower at 12 h
after Li-SWT while SMAD7 was higher expressed in Li-SWT compared to controls. P21 was significant different at 12 h, 24 h and 72 h while SMAD3,
KI67, CYCKLIND1, P53 and CASP3 showed no difference between treatment groups.n = 3, * p < 0.05
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Expression of apoptosis related genes increased during
early regeneration in shockwave treated animals
Expression of the apoptosis related genes Bax, Bcl2 and
Casp3 increased significantly on day 2 in shockwave
treated legs compared to controls, indicating a stronger
onset of apoptosis. The Bax/Bcl2 ratio, which determines
the apoptotic potential [33], peaked at day 3 and de-
creased until day 10 for both groups, reflecting the
muscle degeneration observed as part of the regener-
ation process [34, 35] (Fig. 5a).
Fig. 2 In vitro gene expression of PAX3, PAX7, MYF5, MYOD1, MYOG, MEF2A, HGF and MET during proliferation in control and shockwave treated
myoblasts. MEF2A was significantly increased at 12 h after Li-SWT, while the expression of PAX3, PAX7, MYF5, MYOD1, MYOG, HGF and MET did not
differ between treatment groups.n = 3, * p < 0.05
Fig. 3 The number of MYOG positive myofibers and the fraction of MYOG positive cells during myoblast differentiation after Li-SWT. Myoblasts
were treated with shockwaves and cultured in differentiation medium and harvested 2, 4 and 6 days after Li-SWT. a We found no difference in
the number of myofibers (>2 nuclei) in control and Li-SWT myoblasts, thus cells had maintained their capacity to differentiate after Li-SWT. b The
fraction of MYOG positive nuclei was significantly lower in Li-SWT cultures on day 2 during differentiation. However on day 4 and 6, the MYOG
fractions were not changed by Li-SWT. c Immunohistochemical stainings for MYOG on day 2 after Li-SWT.n = 3, * p < 0.05
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Small effect of Li-SWT on the early inflammatory response
The inflammatory response induced by the cardiotoxin
lesion caused a significant increased Il1a expression on
day 2, and Tnfa on day 3 in the Li-SWT legs, but no dif-
ference in the expression of Il1b, Il6, Ccl2 and Ccr2 was
found between the groups. All genes were initially
expressed at high levels and decreased towards day 10
with no further changes (Fig. 5a).
CD45 staining for inflammatory cells on the histo-
logical sections demonstrated a lesion-induced inflam-
matory cells on day 2 and 3, but no difference was
observed between the groups except on day 21 where
the infiltration was significantly higher in the Li-SWT
legs (Fig. 5b, c).
Thus, a small increase in the early inflammatory signal
may have occurred; however, the overall inflammatory
response was not altered by the Li-SWT.
Li-SWT caused upregulation of myogenic factors in vivo
Pax7, Myf5 and Met gene expressions were significantly
increased on day 2 in the Li-SWT group. No difference
was observed in the expression of Myod1, Myog, Myf6,
Mstn, Hgf, Mef2c and Tgfb1 (Fig. 6a).
Immunohistochemical stainings for the satellite cell
marker PAX7 was made (Fig. 6b) and the stainings were
quantified on day 2 and 3 (Fig. 6c). As expected a higher
density of PAX7 positive cells was observed in the re-
generating areas, however we found no difference in the
number of PAX7+ cells between the treated and control
legs. Likewise, a large number of MYOG+ cells were ob-
served in the regenerating areas on day 2 and 3, however
no difference between Li-SWT and controls was found
(Fig. 6d).
Thus gene expression studies indicate a Li-SWT in-
duced early SC activation though the number of cells ex-
pressing the myogenic markers PAX7 and MYOG was
unaltered.
Li-SWT increased the angiogenic gene expression in vivo
The gene expression of Angpt1, Angpt2, eNos and iNos
were high on day 2 in the Li-SWT group. eNos was sig-
nificantly increased in the Li-SWT group on day 2 and
iNos and Angpt2 showed the same tendency (Fig. 7a).
This could indicate that Li-SWT supports early angio-
genesis during muscle repair. On day 21 Angpt1, eNos,
iNos, Vegfa, and Pecam1 were significantly higher
expressed in Li-SWT treated legs, with Angpt2 and
Vegfr2 having the same tendency (Fig. 7a), indicating a
late effect, too, of Li-SWT, corresponding to previous
studies [21, 36].
CD34 gene expression increased slightly in both
groups from day 10, but there was no difference between
Fig. 4 Quantifications of adherence of explants, outgrowth visualisations, cell adhesion and phalloidin staining of cells after shockwave treatment.
a In explant cultures treated with 300 impulses of 0.1 mJ/mm2 46% of the treated explants adhered compared to 92% in controls (n = 48),
however (b) the number of cells grown out from the explants and their expression of NCAM did not differ. c The experiment was then
performed with human myoblasts isolated by enzyme dissociation. The cells were cultured on coverslips and harvested every 30 min the
first 2 h; no difference in adherence was observed. (d) However, when the harvested coverslips were stained for F-actin with phalloidin,
the shockwave treated cells displayed a much lower expression of F-actin, indicating a delayed actin assembly. The shown images are
from cells harvested 90 min after culture.n = 3, * p < 0.05
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treated and control legs. Furthermore there was no dif-
ference in the Fgf2 expression, a well-known co-player
in angiogenesis [37], while the expression of Fgfr1 was
significantly increased on day 2 in Li-SWT treated com-
pared to control (Fig. 7a).
Quantitation of vessel density by immunohisto-
chemial staining with vWF demonstrated increased
vessel density in the regeneration area compared to
the unaffected area of the muscle, but there was no
difference between treatment groups (Fig. 7b,c).
Though no difference in vessel density was found, the
gene expressions indicate an enhanced angiogenic sig-
nal caused by Li-SWT.
Discussion
Our study is the first to present the effect of Li-
SWT on human myoblast cultures and mouse skel-
etal muscle undergoing regeneration after acute in-
jury. The beneficial effect of Li-SWT treatment on
microcirculation has been documented in various
Fig. 5 Expressions of Bax, Bcl2, Casp3, Il1a, Il1b, Il6, Ccl2, Ccr2 and Tnfα and CD45+ cells during muscle regeneration in control and shockwave
treated mice. a Bax, Bcl2 and Casp3 were highly expressed in the early phase of regeneration, and significantly different in the Li-SWT group on
day 2, while the apoptotic potential, Bax/Bcl2 seemed lower in the Li-SWT group on day 3. Similarly Il1a and Tnfα were significantly higher
expressed in the early phase of regeneration. The expression of Il1b, Il6, Ccl2 and Ccr2 showed similar expression pattern with highest levels from
day 2–5 with no difference between the control and Li-SWT group. b Quantifications of CD45+ cells showed increased lymphocyte infiltration on
day 2 and 3, with the only significant change in the number of CD45+ cells on day 21 in the SWT group. c Immunohistochemical stainings for
CD45 on day 3. n = 3 in gene expressions and n = 4 in quantifications, * p < 0.05
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tissues [21, 25, 38, 39] but not much is known about
how Li-SWT affects the skeletal muscle specific stem
cells.
Li-SWT exerted no harmful effect on human myoblasts
The viability of myoblasts was tested, and within the
range of 300 to 1500 impulses the energy application
Fig. 6 In vivo gene expression of Pax7, Myf5, Myod1, Myog, Mstn, Myf6, Hgf, Met, Mef2c, Tgfb1 and protein expression of PAX7 and MYOG. a Pax7,
Myf5 were significantly increased on day 2 in the Li-SWT group, while Met was significantly increased on day 3 in the Li-SWT group. No difference
was found between treatment groups in the expression of Myod1, Myog, Myf6, Mstn, Hgf, Mef2c and Tgfb1. b Immunohistochemical staining for
PAX7 was made for Li-SWT and controls and the expression on day 3 is shown. c The PAX7 stainings were quantified, and the highest number of
satellite cells (PAX7+) was found as expected in regenerating areas of the muscle, however no difference was observed in the number of PAX7+
cells in Li-SWT compared to control. d The number of MYOG+ cells peaked on day 3 but no difference was observed between the Li-SWT and
control group. MYOG stainings are shown for day 3. n = 3 in gene expressions and n = 4 in quantifications, * p < 0.05
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was well tolerated. For further in vitro studies a dose of
300 impulses of 0.1 mJ/mm2 was used. Similar in vitro
studies have used impulses ranging from 250 to 1000 de-
pending on cell type [17, 19, 40]. When myoblast cul-
tures were treated with Li-SWT we found a very low
level of cell death, comparable to studies conducted on
osteoblasts and fibroblasts [40]. We also found that the
proliferation potential of myoblasts and their ability to
migrate and differentiate was unaffected by the Li-SWT
with the applied dose. Thus Li-SWT was not harmful to
myoblasts.
Li-SWT altered expression of TGFβ1, SMAD7 and MEF2A
during in vitro proliferation
Although Li-SWT had no effect on the number of prolif-
erating cells, we found that the expression of TGFβ1 was
down regulated while SMAD7, P21 and MEF2A were
significantly up regulated in the Li-SWT treated cell
Fig. 7 Expression of Angpt1, Angpt2, eNOS, iNOS, VEGFa, Pecam1, Kdr, CD34, Fgf2 and Fgfr1 and vessel density during muscle regeneration in
control and Li-SWT mice. a Angpt2, eNOS and iNOS were high expressed on day 2 in Li-SWT, with eNOS being significantly higher expressed in
the Li-SWT group. Angpt1, eNOS, iNOS, VEGFa and Pecam1 were significant up regulated on day 21 in the Li-SWT group. Thus Li-SWT induced an
early and late angiogenic signal. No effect of Li-SWT was found in expression of Kdr, CD34, Fgf2, but Fgfr1 was significantly increased in the Li-SWT
group on day 2. b and (c) Blood vessels were visualized by immunostainings for vWF and the vessel density (number of vessels/cm2) peaked on day 3
in regenerating areas before decreasing again. No effect of Li-SWT on vessel density was found in either regenerating- or normal muscle areas. c
Immunostainings for vWF are shown for day 3 in Li-SWT and controls.n = 3 in gene expressions and n = 4 in quantifications, * p < 0.05
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cultures during proliferation. Thus, the TGFβ1 signaling
pathway seemed to be sensitive for shockwave treatment,
however no conclusion on the overall influence of the
pathway can be drawn from the present gene expression
data. MEF2A is crucial for myoblast differentiation [32],
and interestingly, it was significantly up regulated
already 12 h after treatment. In C2C12 MEF2A is in-
creased after mechanical stress in C2C12 myoblasts [41],
thus the Li-SWT induced shear stress may have led to
the up regulation of MEF2A in the human myoblasts.
Myoblast stress tolerance
It is likely that various cell types can withstand different
amount of stress. Tenocytes are often treated with 1000
impulses [16, 17], while cells of endothelial origin, which
are sensitive to flow changes (shear stress) [42], tend to
be treated with 300 impulses [19, 43]. Myoblasts may
have a stress tolerance similar to tenocytes given their
similar niche and ability to sustain continues stretch,
which could explain the lack of effects of Li-SWT on
proliferation and differentiation observed in this study.
Decreased adhesion in explants and cell cultures after
Li-SWT
Stress mechanotransduction can affect the cytoskeleton
and focal adhesion proteins, leading to loss of adhesion
[44]. Likewise, shockwave treatment has been reported
to result in cell detachment in monolayers of cardiac cell
cultures [20] and renal carcinoma cell line [45],. How-
ever, increased adhesion has been reported in suspended
osteoblasts treated with Li-SWT [46]. Thus, the effect of
Li-SWT seems to depend on the method of application
and cell type.
The decreased attachment of Li-SW treated explants
observed in our study could be due to an initial effect of
Li-SWT. Detached renal carcinoma cells showed actin
depolymerisation and altered actin filament organisation
[45]. Likewise, we observed a decreased assembly of F-
actin after Li-SWT. Although we did not observe altered
attachment properties, this indicates an effect of Li-SWT
on myoblast cytoskeleton.
Li-SWT affected the muscle regeneration in mice
In our study Li-SWT significantly increased apoptotic,
pro-inflammatory and myogenic factors in the early
phase of regeneration, probably a result of shockwave-
induced stress in an already necrotic/apoptotic environ-
ment [33].
Although the Bax/Bcl-2 ratio indicated that apoptotic
activity was reduced on day 3 in the treated legs, the sig-
nificant expression of Bax and Casp3 on the previous
day implied a Li-SWT-induced pro-apoptotic gene ex-
pression. Other studies have reported decreased necrosis
and decreased amount of cells undergoing apoptosis in
ischaemic skin flaps after Li-SWT [22, 47], however, an is-
chaemic skin flap is different from regenerating muscle in
an otherwise healthy mouse, and the response upon injury
depends on the type and the extend of the injury, for in-
stance degeneration and regeneration progress faster after
myotoxic injury than after ischaemic lesions [35, 48].
In the inflammatory markers Il1a and Tnfa was signifi-
cantly increased in early regeneration and Il1b and Il6
showed the same tendency. However, quantifications of
leucocytes did not reveal increased infiltration nor was
there any increase in the Ccl2 expression, indicating
similar monocyte/macrophage infiltration [49]. In con-
trast a recent study reported significantly decreased ex-
pression of pro-inflammatory genes and leukocyte
infiltration in burn injuries after Li-SWT [50] and an-
other study reported decreased leukocyte rolling and
transmigration of endothelium after Li-SWT [25].
Though Li-SWT did not augment the number of PAX7
+ satellite cells, an increased expression of Pax7, Myf5 and
Met on day 2, indicate increased SC induction. Thus Li-
SWT may have induced the regenerative response in the
acute muscle injury model, in accordance with reported
observations on the effect of pro-inflammatory cytokines,
HGF release and shear stress [34, 51–53]. The effect might
prove even more beneficial in a chronic injury model,
where the background is suboptimal repair.
Increased angiogenic response in mice
We found in the regenerating muscle an increased ex-
pression of eNOS on day 2 after Li-SWT and the same
tendency was observed in iNOS and Angpt2, indicating
an early angiogenic reponse. Furthermore, Angpt1,
eNOS, iNOS, Vegfa, and Pecam1 gene expressions in-
creased from day 14 to 21 in the Li-SWT group,
The increased eNOS and iNOS expression was most
likely caused by shockwave-induced increase in intracel-
lular calcium, which activates eNOS and iNOS [54]. Fur-
ther, iNOS is induced by pro-inflammatory cytokines
like TNF-a and IL1b [55]. In addition, shear stress is
known to contribute to increased eNOS expression [56]
and increased release of angpt2 from endothelial cells
[57], which could potentially lead to increased
angiogenesis.
Despite Li-SWT induction of pro-angiogenic genes the
vessel density was unaffected, which is in contrast to re-
cent studies reporting increased vessel density after
treatment of ischaemic muscle or skin [23, 24, 26]. Thus,
the injury model, might be crucial for SW-induced ac-
celeration of regeneration. The mice used in the present
study were healthy and thus fully capable of regenerating
a cardiotoxin lesion without Li-SWT. To be demon-
strable a Li-SWT induced angiogenic response may need
to be studied in a disease model where the regeneration
capacity as a starting point is insufficient.
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In a clinical perspective the increased pro-angiogenic
gene expression and the early stimulation of satellite
cells induced by Li-SWT might be beneficial in regener-
ating skeletal muscle injuries. Especially the field of skel-
etal muscle tissue engineering with the use of scaffolds
where activation of myoblasts and proper vascularization
are limiting factors for survival and integration of trans-
planted tissue, treatment with Li-SWT might enhance
the engraftment and regeneration process. Likewise sup-
port of regeneration in muscle lesions in areas with in-
sufficient blood supply might be a target for Li-SWT.
Shockwave treatment is commonly applied to tissues
covered by or adjacent to muscle and thus skeletal
muscle is included in the treatment area. It is therefore
an important information that muscle apparently is not
injured by shockwave treatment.
Many articles have reported the effect of Li-SWT, but
this study describes a large number of genes affected by
Li-SWT, which to our knowledge has never been de-
scribed before.
Conclusions
Our studies have shown, that Li-SWT is well tolerated
and that when applied to muscle stem cells in vitro and
muscle in vivo with a total energy of 0.981 J and 1.635 J
respectively cellular changes were induced that could
promote muscle regeneration.
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